Skip to main content Scroll Top
Most Viewed Posts
Clear Filters
REGEnLIFE attempts to prove that advanced phototherapy can cure Alzheimer’s disease
The neuroprotective effect of a new photobiomodulation technique on Aβ25-35 peptide-induced toxicity dramatically impact gut microbiota dysbiosis
A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance

SantExpo 2026 – Paris / Porte de Versailles | 21 MAI

A presentation of REGEnLIFE’s R&D activities, covering its technologies, how they work, and its medical innovations aimed at new practical applications, followed by a discussion on the challenges and innovations shaping the future of healthcare.

Speakers: Guillaume Blivet, Patrice CRISTOFINI

Thursday 21 May, from 9am to 1pm at SantExpo in Paris, Porte de Versailles, Hall 1, at stand F42 – MEDVALLÉE Montpellier Méditerranée Métropole stand

SantExpo 2026
Share this article